Education
About Us
Working with TipRanks
Follow Us
Biosergen AB (DE:8N1)
:8N1
8N1 Stock Chart & Stats
$0.04
$0.00(0.00%)
At close: 4:00 PM EST
$0.04
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume0.00
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$33.27M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Mar 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)2.64
Price to Sales (P/S)0.00
P/FCF Ratio-7.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Biosergen AB News
8N1 FAQ
What was Biosergen AB’s price range in the past 12 months?
Currently, no data Available
What is Biosergen AB’s market cap?
Currently, no data Available
When is Biosergen AB’s upcoming earnings report date?
Biosergen AB’s upcoming earnings report date is Mar 27, 2026 which is in 112 days.
How were Biosergen AB’s earnings last quarter?
Biosergen AB released its earnings results on Nov 19, 2025. The company reported -$0.472 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.472.
Is Biosergen AB overvalued?
According to Wall Street analysts Biosergen AB’s price is currently Overvalued.
Does Biosergen AB pay dividends?
Biosergen AB does not currently pay dividends.
What is Biosergen AB’s EPS estimate?
Biosergen AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biosergen AB have?
Currently, no data Available
What happened to Biosergen AB’s price movement after its last earnings report?
Biosergen AB reported an EPS of -$0.472 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.181%.
Which hedge fund is a major shareholder of Biosergen AB?
Currently, no hedge funds are holding shares in DE:8N1
Technical Analysis
Alzinova AB
―
Nanologica AB
―
Lipigon Pharmaceuticals AB
―
NextCell Pharma AB
―
Spago Nanomedical AB
―